{
    "Trade/Device Name(s)": [
        "NeoBase 2 Non-derivatized MSMS kit",
        "NeoBase 2 Non-derivatized Assay Solutions",
        "QSight 210 MD Screening System"
    ],
    "Submitter Information": "PerkinElmer, Inc.",
    "510(k) Number": "K193103",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173568"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQL"
    ],
    "Summary Letter Date": "February 7, 2020",
    "Summary Letter Received Date": "November 8, 2019",
    "Submission Date": "November 7, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1055"
    ],
    "Regulation Name(s)": [
        "Newborn Screening Test System for Amino Acids, Free Carnitine, and Acylcarnitines Using Tandem Mass Spectrometry"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine",
        "toxicology"
    ],
    "Analyte(s)": [
        "Alanine",
        "Arginine",
        "Argininosuccinic acid",
        "Citrulline",
        "Glutamine",
        "Lysine",
        "Glutamic acid",
        "Glycine",
        "Leucine",
        "Isoleucine",
        "Hydroxyproline",
        "Methionine",
        "Ornithine",
        "Phenylalanine",
        "Proline",
        "Tyrosine",
        "Valine",
        "Free carnitine",
        "Acetylcarnitine",
        "Propionylcarnitine",
        "Malonylcarnitine",
        "3-Hydroxy-butyrylcarnitine",
        "Butyrylcarnitine",
        "Methylmalonylcarnitine",
        "3-Hydroxy-isovalerylcarnitine",
        "Isovalerylcarnitine",
        "Tiglylcarnitine",
        "Glutarylcarnitine",
        "3-Hydroxy-hexanoylcarnitine",
        "Hexanoylcarnitine",
        "Adipylcarnitine",
        "Octanoylcarnitine",
        "Octenoylcarnitine",
        "Decanoylcarnitine",
        "Decenoylcarnitine",
        "Decadienoylcarnitine",
        "Dodecanoylcarnitine",
        "Dodecenoylcarnitine",
        "Tetradecanoylcarnitine",
        "Myristoylcarnitine",
        "Tetradecenoylcarnitine",
        "Tetradecadienoylcarnitine",
        "3-Hydroxy-tetradecanoylcarnitine",
        "Hexadecanoylcarnitine",
        "Palmitoylcarnitine",
        "Hexadecenoylcarnitine",
        "3-Hydroxy-hexadecanoylcarnitine",
        "3-Hydroxy-hexadecenoylcarnitine",
        "Heptadecanoylcarnitine",
        "Octadecanoylcarnitine",
        "Stearoylcarnitine",
        "Octadecenoylcarnitine",
        "Oleylcarnitine",
        "Octadecadienoylcarnitine",
        "Linoleylcarnitine",
        "3-Hydroxy-octadecanoylcarnitine",
        "3-Hydroxy-octadecenoylcarnitine",
        "3-Hydroxy-octadecadienoylcarnitine",
        "Succinylacetone",
        "Adenosine",
        "2'-deoxyadenosine",
        "C24:0 lysophosphatidylcholine",
        "C26:0 lysophosphatidylcholine"
    ],
    "Specimen Type(s)": [
        "Dried blood spot from newborn heel prick"
    ],
    "Specimen Container(s)": [
        "Filter paper (e.g., Whatman no. 903)"
    ],
    "Instrument(s)/Platform(s)": [
        "QSight 210 MD Mass Spectrometer",
        "QSight HC Autosampler MD",
        "QSight Binary Pump MD",
        "Simplicity 3Q MD Software",
        "PerkinElmer MSMS Workstation software"
    ],
    "Method(s)/Technology(ies)": [
        "Tandem mass spectrometry",
        "Analyte-specific mass transitions",
        "Isotope-labeled internal standards"
    ],
    "Methodologies": [
        "Quantitative analysis",
        "Mass spectrometry profiling"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Control",
        "Software",
        "Analyzer",
        "Platform",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for NeoBase 2 Non-derivatized MSMS kit for multiplex newborn metabolic disorder screening via tandem mass spectrometry from dried blood spots",
    "Indications for Use Summary": "Measurement and evaluation of amino acid, succinylacetone, free carnitine, acylcarnitine, nucleoside, and lysophospholipid concentrations in dried blood spots from newborns using tandem mass spectrometry to aid in metabolic disorder screening",
    "fda_folder": "Clinical Chemistry"
}